DENTSPLY SIRONA (NASDAQ:XRAY) Raised to "Buy" at Wall Street Zen

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Sunday.

A number of other equities research analysts have also recently issued reports on XRAY. Piper Sandler cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a report on Tuesday, April 15th. Barrington Research increased their target price on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday, May 12th. Finally, UBS Group reduced their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA presently has a consensus rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $16.21 on Friday. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $27.95. The company has a fifty day moving average of $15.94 and a 200-day moving average of $16.38. The company has a market capitalization of $3.23 billion, a P/E ratio of -3.57, a P/E/G ratio of 1.16 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.42 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently bought and sold shares of the stock. AQR Capital Management LLC grew its holdings in shares of DENTSPLY SIRONA by 119.4% during the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier's stock worth $93,423,000 after acquiring an additional 3,453,662 shares during the period. Nuance Investments LLC raised its holdings in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Norges Bank purchased a new position in DENTSPLY SIRONA during the fourth quarter valued at $45,730,000. Goldman Sachs Group Inc. grew its position in shares of DENTSPLY SIRONA by 827.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier's stock worth $36,378,000 after buying an additional 2,172,343 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of DENTSPLY SIRONA by 18.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after acquiring an additional 1,975,404 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.